Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Catalyst Pharmaceuticals Inc. (CPRX)

  • SEC News
  • Jan. 06, 2026, 22:00 UTC
  • 8
  • 1 comments

Director Daly Richard J 🟡 adjusted position in 10.6K shares (1 derivative) of CATALYST PHARMACEUTICALS, INC. (CPRX) Transaction Date: Jan 05, 2026 | Filing ID: 000021

Comment Full text

Oncotelic Therapeutics, Inc. (OTLC)

  • SEC News
  • Jan. 06, 2026, 22:00 UTC
  • 8
  • 1 comments

(99% Neutral) ONCOTELIC THERAPEUTICS, INC. (OTLC) Announces Business Combination

Comment Full text

AptarGroup Inc (ATR)

  • Business News
  • Jan. 06, 2026, 22:00 UTC
  • 8
  • 1 comments

Aptar - Aptar Digital Health and ŌURA Collaborate to Advance Migraine Insights by Connecting Migraine Buddy®with Oura Ring

Market reaction Comment Full text

Amarin Corporation Plc (AMRN)

  • SEC News
  • Jan. 06, 2026, 22:00 UTC
  • 8
  • 1 comments

Fishman Peter L. 🟡 adjusted position in 3.5K shares (1 derivative) of AMARIN CORP PLC\UK (AMRN) at $13.96 Transaction Date: Jan 02, 2026 | Filing ID: 004724

Comment Full text

Amarin Corporation Plc (AMRN)

  • SEC News
  • Jan. 06, 2026, 22:00 UTC
  • 8
  • 1 comments

Keenan David Paul 🟡 adjusted position in 5.5K shares (1 derivative) of AMARIN CORP PLC\UK (AMRN) at $13.96 Transaction Date: Jan 02, 2026 | Filing ID: 004722

Comment Full text

Amarin Corporation Plc (AMRN)

  • SEC News
  • Jan. 06, 2026, 22:00 UTC
  • 8
  • 1 comments

Provoost Jonathan 🟡 adjusted position in 5.9K shares (1 derivative) of AMARIN CORP PLC\UK (AMRN) at $13.96 Transaction Date: Jan 02, 2026 | Filing ID: 004719

Comment Full text

Amarin Corporation Plc (AMRN)

  • SEC News
  • Jan. 06, 2026, 22:00 UTC
  • 8
  • 1 comments

Ketchum Steven B 🟡 adjusted position in 5.3K shares (1 derivative) of AMARIN CORP PLC\UK (AMRN) at $13.96 Transaction Date: Jan 02, 2026 | Filing ID: 004718

Comment Full text

GE HealthCare Technologies Inc (GEHC)

  • Business News
  • Jan. 06, 2026, 22:00 UTC
  • 8
  • 1 comments

GE HealthCare Recommends Shareholders Reject “Mini-Tender” Offer by Potemkin Limited

Market reaction Comment Full text

AptarGroup Inc (ATR)

  • Business News
  • Jan. 06, 2026, 22:00 UTC
  • 8
  • 1 comments

Aptar Digital Health and ŌURA Collaborate to Advance Migraine Insights by Connecting Migraine Buddy® with Oura Ring

Market reaction Comment Full text

Acumen Pharmaceuticals Inc (ABOS)

  • SEC News
  • Jan. 06, 2026, 21:59 UTC
  • 7
  • 1 comments

📋 Meisner Derek M (Officer) plans to sell 11K shares of Acumen Pharmaceuticals, Inc. (at $1.97 each, total $21K) Filed: Jan 06, 2026 | ID: 000015

Comment Full text

Werewolf Therapeutics Inc (HOWL)

  • SEC News
  • Jan. 06, 2026, 21:59 UTC
  • 7
  • 1 comments

📋 MPM Asset Management LLC (Shareholder) plans to sell 31K shares of Werewolf Therapeutics, Inc. (at $0.64 each, total $20K) Filed: Jan 06, 2026 | ID: 000958

Comment Full text

Cibus Inc (CBUS)

  • SEC News
  • Jan. 06, 2026, 21:59 UTC
  • 7
  • 1 comments

(99% Neutral) Cibus, Inc. (CBUS) Announces Business Combination

Comment Full text

Werewolf Therapeutics Inc (HOWL)

  • SEC News
  • Jan. 06, 2026, 21:58 UTC
  • 7
  • 1 comments

📋 MPM Asset Management Investors BV2014 LLC (Shareholder) plans to sell 7K shares of Werewolf Therapeutics, Inc. (at $0.64 each, total $4K) Filed: Jan 06, 2026 | ID: 000956

Comment Full text

Werewolf Therapeutics Inc (HOWL)

  • SEC News
  • Jan. 06, 2026, 21:57 UTC
  • 7
  • 1 comments

📋 MPM BioVentures 2014 (B), L.P. (Shareholder) plans to sell 13K shares of Werewolf Therapeutics, Inc. (at $0.64 each, total $9K) Filed: Jan 06, 2026 | ID: 000954

Comment Full text

Werewolf Therapeutics Inc (HOWL)

  • SEC News
  • Jan. 06, 2026, 21:56 UTC
  • 7
  • 1 comments

📋 UBS Oncology Impact Fund, L.P. (Shareholder) plans to sell 164K shares of Werewolf Therapeutics, Inc. (at $0.64 each, total $106K) Filed: Jan 06, 2026 | ID: 000951

Comment Full text
  • Previous
  • 725
  • 726
  • 727
  • 728
  • 729
  • Next

Search

News categories

  • Technical Exchange News(10969)
  • Event(2441)
  • SEC News(193597)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(125902)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin